Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 1488 Cisplatin 1410 Paclitaxel 1316 Radiotherapy 1259 Carboplatin 1247 Gemcitabine 1214 Docetaxel 1110 Bevacizumab 1029 Fluorouracil 894 Doxorubicin 786 Dexamethasone 746 Rituximab 719 Capecitabine 716 Oxaliplatin 700 pembrolizumab 673 Etoposide 673 Irinotecan 634 Filgrastim 621 Cytarabine 584 Leucovorin 578 Nivolumab 557 Vincristine 510 Prednisone 474 Cetuximab 464 Bortezomib 457 Erlotinib Hydrochloride 456 Trastuzumab 448 Methotrexate 437 Lenalidomide 426 Pemetrexed 419

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × mifamurtide × Clear all

NCT01459484 2024-05-20

ISG/OS-2

Italian Sarcoma Group

Phase 2 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡